European pharma plans new strategies for R&D
Interviewee/Contributor
Jean-Claude Muller
Organisation
MedNous
Research Directory
Using nanotechnology to improve AIDS medication
Interviewee/ContributorPeter CharlishOrganisationMedNousPatch up the pain: A case study in transdermal drug delivery
Interviewee/ContributorVasiliki Nikolaou and David HaddletonOrganisationMedherant LtdNon-governmental drug assessments in the US
Interviewee/ContributorSteven PearsonOrganisationInstitute for Clinical and Economic ReviewMandatory joint EU assessments are coming at last
Interviewee/ContributorKaren FinnOrganisationMedNousHow genome editing is impacting cell therapy
Interviewee/ContributorJonathan MooreOrganisationHorizon Discovery Group PlcAcesion Pharma's new approach to atrial fibrillation
Interviewee/ContributorMorten GrunnetOrganisationAcesion Pharma ApSEuropean biotechs mixed in quarter
Interviewee/ContributorWilliam EllingtonWhat Roche's takeover of Flatiron Health really means
Interviewee/ContributorTara RaveendranOrganisationShore CapitalInnate Pharma aims to regain leadership in IO
Interviewee/ContributorRobin DavisonOrganisationNew Science Global Healthcare Fund